GI-4000

N/A

Report date: 2024/12/13 20:00:39

Base Information

Drug NameGI-4000
Drug Alias NameGI-4000
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionNatural killer cells stimulantsImmunostimulantsGTPase Ras inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColonic Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlobeimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunitybio IncGeorgetown UniversityGlobeimmune Inc +[5] 
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColonic Neoplasms +[9] 

Other Information

ATC CodeN/A
Related LinksN/A